• There are no suggestions because the search field is empty.

PRRC under MDR and IVDR: meaning, requirements, and responsibilities

Calander_icon
person-image
Caroline Aernouts, Senior Regulatory Specialist at QbD Group
The Medical Device Regulation (MDR) (EU) 2017/745 and In Vitro Device Regulation (IVDR) (EU) 2017/746 introduced a new mandatory role in Article 15: the Person Responsible for Regulatory Compliance or 'PRRC'. Wondering what the meaning of the PRRC-role is and where you can find the right person? Then read on!
PRRC under MDR and IVDR: meaning, requirements, and responsibilities | QbD Group
5:41

PRRC: meaning of this new role under MDR and IVDR

 

The Person Responsible for Regulatory Compliance or ‘PRRC’ is a mandatory role introduced by the Medical Device Regulation (MDR), which came into force in May 2021, and the In Vitro Medical Devices Regulation (IVDR), which came into force on the 26th of May 2022.

Article 15 of both regulations announced this with some main clear guidelines on the need to have the necessary PRRC qualifications, requirements and responsibilities listed.

It also indicates who can be designated to take on this role in the case of ‘micro and small enterprises’, as these do not always have the necessary qualified staff. This is one of the topics that will be discussed in this blog post.

Other topics to be discussed are:

  • What does the regulation mean by the necessary qualifications?

  • When do you need to contact your PRRC?

  • What if you need a PRRC and an authorized representative?

Keep on reading if you want to deep dive into the meaning of this new PRRC role with some practical guidance!


PRRC requirements from the MDR and IVDR

Micro and small enterprises

The MDR and IVDR mention  “micro and small enterprises”. Why is that? Because many spin-offs and other small manufacturers simply do not have a regulatory person in their workforce. Fortunately, they can outsource this role. But which companies are considered “micro and small”? The MDR and IVDR refer to the “ Commission Recommendation 2003/361/ΕC of 6 May 2003 concerning the definition of micro, small and medium-sized enterprises”:

  • A micro-enterprise has less than 10 employees and less than an annual turnover and/ or annual balance sheet total that does not exceed € 2 million.
  • A small enterprise has less than 50 employees and less than an annual turnover and/ or annual balance sheet total that does not exceed € 10 million.
They have the privilege to subcontract a PRRC, who will be continuously and permanently at their disposal.

 

PRRC qualifications under MDR and IVDR

Who can act as a PRRC? Which experiences are required? The MDR and IVDR state the following:

(a) a diploma, certificate or other evidence of formal qualification, awarded on completion of a university degree or of a course of study recognised as equivalent by the Member State concerned, in law, medicine, pharmacy, engineering or another relevant scientific discipline, and at least one year of professional experience in regulatory affairs or in quality management systems relating to medical devices;

(b) four years of professional experience in regulatory affairs or in quality management systems relating to medical devices.

Neither the regulations nor the guidance document of the MDCG 2019-7 provide interpretations of the other relevant disciplines.

It is clear, however, that the diploma or certificate obtained outside the EU should be recognized by a member of the EU as equivalent to a corresponding qualification in the EU.

 

PRRC responsibilities under MDR and IVDR

If you are a micro and small business and wish to outsource a PRRC, it is useful to know the exact meaning of the PRRC role, what the responsibilities are and when you should involve them. The role and responsibilities of the PRRC include ensuring:

  • the conformity device meets regulatory standards
  • technical documentation is established and maintained
  • post-market surveillance activities are compliant with regulations
  • incidents are recorded and reported and that field safety corrective actions are implemented
  • statement has been issued in case of investigational devices (MDR) or IVD devices intended for use in interventional clinical effectiveness studies (IVDR)
 

It should be made clear that it is not necessarily up to the PRRC to write the above references. But he must ensure that these requirements are met.

He takes the responsibility for the conformity of the product before the Notified Body or the Competent Authority, but this does not mean that he is the only spokesperson during an audit.

It is up to the manufacturer to inform the PRRC about planned audits, QMS, product changes, any complaints, recalls, or field safety issues. The PRRC is permanently and continuously available to the manufacturer for example in case of unannounced audits.

The PRRC cannot act as an authorized representative. The Medical Device Coordination Group (MDCG) has expressed a desire within the regulations for the authorized representative to add an additional level of scrutiny

This ensures that the supervision and control of the manufacture of devices, and the relevant post-market surveillance and vigilance activities are carried out in an appropriate manner. If the two roles were fulfilled by the same person, the additional level of scrutiny would be undermined. 

For the same reason, the PRRC of a micro or small enterprise and the PRRC of the authorized representative of that same enterprise should not belong to the same external organization.

 

Conclusion: ensure MDR and IVDR compliance via a PRRC


The introduction of the PRRC under MDR and IVDR brings many questions from manufacturers. What is the meaning of the PRRC and what are the requirements and responsibilities? 

For medium and large enterprises, this role can be taken up by a regulatory person on their own payroll. However, for micro and small enterprises, the MDR and IVDR entail additional efforts. 

However, this role is intended to ensure that the devices are brought to the market in a safe and effective manner.

 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Discover more expert content

preview_image
Case study

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader​

QbD Group streamlines linguistic reviews for a leading pharma client, ensuring compliance and accuracy across 25 EU/EEA languages while meeting stringent regulatory deadlines.
preview_image
Whitepaper

Medical Device Regulation (MDR) Checklist

Implement the Medical Device Regulation (MDR) with ease. Download our checklist of mandatory documents for MDR compliance.
preview_image
Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
preview_image
Webinar

Drug-Device Combination Products and Article 117

Explore the regulatory complexities of Drug-Device Combination Products. Learn about Article 117 requirements, Notified Body Opinions, and more.
preview_image
Whitepaper

Mobile health on the rise: exploring the regulatory landscape for reimbursement

This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.
preview_image
Whitepaper

Clinical investigations under MDR: key insights and practical experiences

This whitepaper covers clinical investigation authorization under MDR, the EU Legal Representative's role, and the MDR's impact on study conduct and post-market surveillance.
preview_image
Case study

CE Mark Renewal for bioXtra Products: A Success Story

Discover how Lifestream Pharma successfully renewed the CE mark for their BioXtra Dry Mouth products under the EU MDR. Learn about the challenges faced, the approach taken for compliance, and the results achieved.
preview_image
Webinar

Technical Documentation Essentials for Medical Device Software

Gain practical insights on crafting MDR-compliant technical documentation for Medical Device Software.
preview_image
Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.
preview_image
Webinar

Mastering Clinical Performance Studies under IVDR

In the evolving regulatory landscape of IVDs, demonstrating clinical performance is more crucial and challenging than ever. Discover more in this webinar on demand.
preview_image
Whitepaper

Clinical evidence for In Vitro Diagnostics under IVDR

In this whitepaper, we will guide you through the documents required for the demonstration of clinical evidence under the IVDR. Download now.
preview_image
Webinar

Post-Market Surveillance Requirements for Medical Devices and IVDs

Learn about post-market surveillance requirements under MDR and IVDR regulations. Gain insights from industry experts in this on-demand webinar.
preview_image
Whitepaper

The key role of Regulatory Affairs in the pharmaceutical industry: from drug development to commercialization

Discover the key role of Regulatory Affairs in pharma and how Regulatory Affairs teams support product lifecycle management in this whitepaper. Download now.
preview_image
Webinar

3D Printing in the Healthcare World

Explore the challenges and opportunities of 3D printing in healthcare, featuring expert insights on regulations, pitfalls, and efficiency.
preview_image
Webinar

IVDR Extension Explained: Tips & Strategies

Gain valuable insights on the IVDR extension and its impact on IVD manufacturers with our webinar on demand.
preview_image
Whitepaper

Innovations in ATMP: state of the industry in 2024

This whitepaper explores the innovations in ATMP and solutions in detail, with a focus on the current landscape as of April 2024. Download now.
preview_image
Case study

The journey toward IVDR compliance for the LVOne device

QbD Group helped Upfront Diagnostics gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.
preview_image
Case study

Ensuring a smooth MDR transition for Oystershell's medical devices

The landscape of medical device regulations is constantly evolving, making it a challenge for companies to keep up. Our collaboration with Oystershell, which began in July 2023, highlights our expertise in transforming complex challenges into success stories, all with a touch of QbD Clinical magic.
preview_image
Case study

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

QbD Clinical assisted Minze Health, a urology-focused medical devices company, in obtaining CE marking under MDR through clinical evaluation.
preview_image
Webinar

The Medical Device CE Certification Pathway Explained: From Classification to Conformity Assessment by the Notified Body

Learn about the Medical Device CE Certification Pathway, from classification to conformity assessment by a Notified Body. Join our webinar on demand.
preview_image
Case study

Helping Relu to comply with changing regulations

QbD Group supported software company Relu with their expertise to comply with changing regulations.
preview_image
Case study

Quickly bringing a new COVID-19 medical device to market

Obtaining the required government certifications for a medical device is always a challenge. Especially when the COVID clock is ticking.